Actelion receives USD 7 million following entry into man of a new renin inhibitor
Actelion/Merck Renin alliance achieves third milestone
07-Jul-2006 -
Actelion Ltd. announced that the renin alliance with Merck & Co., Inc., has achieved its third milestone. The alliance has entered into man its first compound, a new renin inhibitor. This start of full clinical development triggers a milestone payment by Merck to Actelion of USD 7 ...
Actelion
diseases
Formation
+7